Showing results (41-50 of 246) with videos related to
Sort By:
Pageof 25
The Journal of Urology|January 1, 1980
Treatment of recurrent calcium stone formation with cellulose phosphateU Backman, B G Danielson, G Johansson, et al.Lancet (London, England)|September 23, 1989
Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloidM Lindsjö, B Fellström, S Ljunghall, et al.Artificial Organs|September 1, 1993
Complement activation during tryptophan immunoadsorption treatmentA A Alarabi, B Nilsson, U Nilsson, et al.Acta Paediatrica (Oslo, Norway : 1992)|January 1, 1992
Artificial renal and liver support in a severe hepatorenal syndrome of childhoodA A Alarabi, B G Danielson, B Wikström, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1990
Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltrationA A Alarabi, O Cars, B G Danielson, et al.Journal of Human Hypertension|March 1, 1996
Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over studyT Linde, B Sandhagen, A Hägg, et al.Acta Physiologica Scandinavica|May 15, 2001
Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonographyG Metry, C Hall, B Wikström, et al.Clinical Nephrology|November 1, 1988
Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltrationL G Weiss, O Cars, B G Danielson, et al.Journal of the American College of Nutrition|January 1, 1982
Effects of magnesium hydroxide in renal stone diseaseG Johansson, U Backman, B G Danielson, et al.Journal of Clinical Apheresis|January 14, 1999
Identification of complement activators and elucidation of the fate of complement activation products during extracorporeal plasma purification therapyJ E Fadul, A A Alarabi, B Wikström, et al.Pageof 25